Atricure Inc. launches at the 2008 STS-AATS, Fort Lauderdale, the newest Micropace product based on the EPS320 platform – the ORLab™, a new Cardiac Stimulator/EP Recorder System targeted at Cardiac Operating Theatres. The ORLab™ is fully compatible with Atricure’s bipolar clamp technology and provides an easy to use tool to aid in the rapid validation...
Micropace is proud to announce the regulatory clearance for sale in Japan of its EPS320 Touch screen cardiac stimulator for distribution by Medicon, Inc. a Japanese distributor of medical equipment partly owned by C.R. Bard, Inc. Micropace plans to increase sales in 2008 by serving the Japanese market with bundled and stand alone sales of...
Micropace announces the clearance for sale in the USA by FDA of its new StimLab™ Cardiac Stimulator, following clearance for the EU market in the previous month. The StimLab™ is a robust flexible EP laboratory-wide cardiac stimulation system, incorporating a fully featured bedside touch screen stimulator controller. Other companies have answered to physicians’ long standing...
Micropace has opened its US Headquarters on 1 March 2007 at: Suite K, Building 3 1582 Parkway Loop, Tustin CA 92780 Tel: 714-258-7025 Fax: 714-258-7280 Email: support@micropaceEP.com US branch Objectives Serve and facilitate customer needs in upgrading of obsolete hardware stimulators in US Hospitals. Provide a local product supply & delivery, support, service and education for...
In response to new market demands for our cardiac stimulators in the USA, Micropace is establishing an US office “Micropace EP, Inc” to be located in Tustin, CA by early 2007. The office will initially offer logistic services for urgent orders and product support resources for distributors and customers where needed. Micropace has commenced development...
A recently circulated Boston Scientific internal company test report (M.Pare et al, 24.July 2006) showed that a popular hardware EP stimulator exhibited potentially arrhythmogenic nett DC voltages on its pacing outputs when the pacing bipole is located near the ablation catheter during delivery of RF ablation energy. [This is presumably due to partial rectification by...
Micropace is nearing completion of testing on the Stimlab™ dual touch screen stimulator system, which will now be submitted for regulatory approval. This system allows simultaneous dual touch screen control of cardiac stimulator from the control room and by the physician at the bedside. The bedside touch screen may be fixed permanently or may be...
Micropace has responded to growing demands for its product following recent events involving Fisher imaging and its Bloom Electrophysiology Programmable Stimulator. Micropace has further increased production, currently 40% higher compared to previous year period. Micropace has also completed testing on Software Ver 3.21, which now supports the specialised functions provided by this hardware stimulator, allowing...
Micropace and GE Healthcare partnership strengthens with a decision by GE Healthcare to offer a specifically GE configured Micropace EPS320 Cardiac Stimulator as a default stimulator with the CardioLab II. All Micropace stimulator shipments by GE Healthcare will now automatically contain the popular touch screen and four channel options, together with specific configuration optimised for...
Micropace announces release of a service release to its Touch Screen software Ver 3.20, featuring: Multilanguage software interface support – including French, German, Italian and Spanish software screens, menus and help files. New easier method of software upgrade via USB Flash drive Improved touch screen calibration menu Correction of issue of rare software freeze.